Kereos
Kereos is a biotechnology company developing molecular imaging agents and therapeutics to treat cancer and cardiovascular diseases.
Kereos is a business in biotechnology, health care, life science, therapeutics based in Midwestern US, founded in 1999.
Kereos is positioned in biotechnology, health care, life science, therapeutics, a segment that rewards a clear, focused offering.
The company is recorded as being based in Midwestern US.
The company is listed at the Debt_Financing stage of development.
Recorded headcount: c_00001_00010 employees.
Public records show total funding of about $27.2M.
| Sector | Biotechnology, Health Care, Life Science, Therapeutics |
|---|---|
| Headquarters | Midwestern US |
| Founded | 1999 |
| Employees | c_00001_00010 |
| Stage | debt_financing |
| Total funding | $27,189,954 |
Website: kereos.com
Browse related
Emails and contact routes are reserved for registered members.
Create a free account
Create a free account